Merck taps Italian CRO IRBM for peptide drug development

By Melissa Fassbender contact

- Last updated on GMT

(Image: Getty/scyther5)
(Image: Getty/scyther5)

Related tags: Merck & co, MSD, Peptide synthesis, Peptides, Contract research, Contract research organization, CRO

IRBM and Merck have signed a new agreement in the peptide therapeutics area through which the Italian CRO will identify potential peptide leads for a specific Merck target.

The Italy-headquartered contract research organization (CRO) IRBM has been collaborating with Merck & Co., Inc. (known as MSD outside the US and Canada) since 2010.

IRBM will be applying its capabilities in phage display peptide library design and screening, as well as in chemical peptide synthesis and optimization, according to the company.

“At MSD, evaluating the potential of peptide-based therapeutic candidates is a key part of our discovery strategy,” ​said Emma Parmee, VP of global discovery chemistry, MSD, ​in a press release.

“Our R&D peptide group have extensive expertise to help deliver high quality peptide drugs for a wide variety of therapeutic indications,” ​said Carlo Toniatti, CSO at IRBM. “We are thrilled to be collaborating on this project as part of our mission to advance impactful agents into the clinic.”

Related news

Show more

Related products

Q2 Solutions: Corporate Brochure

Q2 Solutions: Corporate Brochure

Q2 Solutions | 17-Apr-2020 | Product Brochure

We are an innovative, progressive and responsive partner with the global experience, medical expertise and focus on quality that is integral to drug, medical...

Global Clinical Trial Lab Services

Global Clinical Trial Lab Services

Q2 Solutions | 01-Apr-2020 | Product Presentation

As a leading global lab services partner, we provide operational excellence, scientific leadership and innovation through technology. We offer end-to-end...

Manufacturing Cyto and Non-Cyto Drugs in One Facility

Manufacturing Cyto and Non-Cyto Drugs in One Facility

Baxter BioPharma Solutions | 01-Mar-2020 | Technical / White Paper

Recent market reports suggest increasing product niches, which may lead to decreasing numbers of units per product, making dedicated facilities less practical....

Related suppliers

Follow us


View more